scholarly article | Q13442814 |
P2093 | author name string | Hai-Long Zhang | |
Heng Xu | |||
Li-Ping Chen | |||
Wen Shen | |||
Xue-Ming Hu | |||
Zhi-Qiang Pan | |||
Shou-Bin Cao | |||
Dong-Mei Lyu | |||
P2860 | cites work | Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor | Q24603928 |
MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling | Q39001808 | ||
Early single Aspirin-triggered Lipoxin blocked morphine anti-nociception tolerance through inhibiting NALP1 inflammasome: Involvement of PI3k/Akt signaling pathway | Q39186615 | ||
When it comes to opiates, just say NO. | Q39328240 | ||
Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. | Q41002806 | ||
Loose ligation of the sciatic nerve is associated with TrkB receptor-dependent decreases in KCC2 protein levels in the ipsilateral spinal dorsal horn | Q41850100 | ||
Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation | Q43192659 | ||
Involvement of a spinal brain-derived neurotrophic factor/full-length TrkB pathway in the development of nerve injury-induced thermal hyperalgesia in mice | Q44241806 | ||
The development of morphine tolerance and dependence is associated with translocation of protein kinase C. | Q45080390 | ||
Effects of chronic morphine treatment on protein expression in rat dorsal root ganglia | Q45718272 | ||
Activation of peripheral ephrinBs/EphBs signaling induces hyperalgesia through a MAPKs-mediated mechanism in mice | Q46427014 | ||
Activation of TRPV1 contributes to morphine tolerance: involvement of the mitogen-activated protein kinase signaling pathway. | Q46570486 | ||
Hydroxymethylation of microRNA-365-3p Regulates Nociceptive Behaviors via Kcnh2. | Q47583465 | ||
Epigenetic modification of spinal miR-219 expression regulates chronic inflammation pain by targeting CaMKIIγ. | Q47842547 | ||
Direct evidence for the involvement of brain-derived neurotrophic factor in the development of a neuropathic pain-like state in mice | Q48925048 | ||
Disruption of calmodulin-dependent protein kinase II α/brain-derived neurotrophic factor (α-CaMKII/BDNF) signalling is associated with zinc deficiency-induced impairments in cognitive and synaptic plasticity. | Q50735883 | ||
An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons | Q24810749 | ||
Noncoding RNAs: key molecules in understanding and treating pain | Q26998622 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence | Q28260467 | ||
Up-regulation of dorsal root ganglia BDNF and trkB receptor in inflammatory pain: an in vivo and in vitro study | Q28567640 | ||
Many roads to maturity: microRNA biogenesis pathways and their regulation | Q29615469 | ||
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain | Q29616106 | ||
Ethical guidelines for investigations of experimental pain in conscious animals | Q29617510 | ||
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia | Q29620385 | ||
PAR2-mediated upregulation of BDNF contributes to central sensitization in bone cancer pain | Q33637280 | ||
Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions | Q33679560 | ||
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab. | Q34205052 | ||
BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis | Q34442760 | ||
Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro | Q34548464 | ||
MicroRNA networks direct neuronal development and plasticity. | Q35644179 | ||
Differential expression of CaMKII isoforms and overall kinase activity in rat dorsal root ganglia after injury | Q35798313 | ||
Pannexin-1 Up-regulation in the Dorsal Root Ganglion Contributes to Neuropathic Pain Development | Q35860828 | ||
Morphine-induced changes of gene expression in the brain | Q36105247 | ||
BDNF in sensory neurons and chronic pain | Q36413814 | ||
Glucocorticoid receptors recruit the CaMKIIα-BDNF-CREB pathways to mediate memory consolidation | Q36431262 | ||
Neurotrophins: mediators and modulators of pain. | Q36507606 | ||
MicroRNA 339 down-regulates μ-opioid receptor at the post-transcriptional level in response to opioid treatment | Q36534353 | ||
BK channels in microglia are required for morphine-induced hyperalgesia. | Q36973985 | ||
BDNF as a pain modulator | Q37178450 | ||
Spinal matrix metalloproteinase-9 contributes to physical dependence on morphine in mice | Q37347626 | ||
Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons | Q37507494 | ||
Morphine regulates expression of μ-opioid receptor MOR-1A, an intron-retention carboxyl terminal splice variant of the μ-opioid receptor (OPRM1) gene via miR-103/miR-107. | Q37553516 | ||
MicroRNAs regulate neuronal plasticity and are involved in pain mechanisms. | Q37576742 | ||
CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord | Q37718182 | ||
MicroRNAs and neurodegeneration: role and impact | Q38048423 | ||
MicroRNAs and Molecular Mechanisms of Neurodegeneration. | Q38202497 | ||
Noncoding RNAs: new players in chronic pain | Q38205120 | ||
MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions | Q38239608 | ||
On the possible role of ERK, p38 and CaMKII in the regulation of CGRP expression in morphine-tolerant rats | Q38668785 | ||
P921 | main subject | morphine | Q81225 |
P577 | publication date | 2016-09-05 | |
P1433 | published in | Molecular Pain | Q15766244 |
P1476 | title | Downregulation of miR-219 enhances brain-derived neurotrophic factor production in mouse dorsal root ganglia to mediate morphine analgesic tolerance by upregulating CaMKIIγ. | |
P478 | volume | 12 |
Q38963958 | Effect of TGF-β/smad signaling pathway blocking on expression profiles of miR-335, miR-150, miR-194, miR-27a, and miR-199a of hepatic stellate cells (HSCs) |
Q93109168 | Hsa-miR-34a-5p and hsa-miR-375 as Biomarkers for Monitoring the Effects of Drug Treatment for Migraine Pain in Children and Adolescents: A Pilot Study |
Q55428388 | Inhibition of Histone Deacetylases Attenuates Morphine Tolerance and Restores MOR Expression in the DRG of BCP Rats. |
Q64091978 | Involvement of brain-derived neurotrophic factor (BDNF) in chronic intermittent stress-induced enhanced mechanical allodynia in a rat model of burn pain |
Q49721945 | MicroRNA-322 Cluster Promotes Tau Phosphorylation via Targeting Brain-Derived Neurotrophic Factor |
Q53409149 | Sonic hedgehog signaling in spinal cord contributes to morphine-induced hyperalgesia and tolerance through upregulating brain-derived neurotrophic factor expression. |
Q92644109 | The Emerging Perspective of Morphine Tolerance: MicroRNAs |
Q55315782 | The Regulatory Mechanisms and Therapeutic Potential of MicroRNAs: From Chronic Pain to Morphine Tolerance. |
Q33758527 | Upregulation of miR-375 level ameliorates morphine analgesic tolerance in mouse dorsal root ganglia by inhibiting the JAK2/STAT3 pathway |
Q33709635 | miR-219-5p targets CaMKIIγ to attenuate morphine tolerance in rats |
Search more.